Alector (ALEC) Shares Outstanding (Entity) (2018 - 2026)
Analysis
Alector (ALEC) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 111.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.66 Mn |
| Mar 31, 2026 | 111.03 Mn |
| Dec 31, 2025 | 110.36 Mn |
| Sep 30, 2025 | 107.45 Mn |
| Jun 30, 2025 | 101.21 Mn |
| Mar 31, 2025 | 99.99 Mn |
| Dec 31, 2024 | 99.09 Mn |
| Sep 30, 2024 | 97.93 Mn |
| Jun 30, 2024 | 97.32 Mn |
| Mar 31, 2024 | 96.38 Mn |
| Dec 31, 2023 | 84.88 Mn |
| Sep 30, 2023 | 84.14 Mn |
| Jun 30, 2023 | 83.83 Mn |
| Mar 31, 2023 | 83.35 Mn |
| Dec 31, 2022 | 82.90 Mn |
| Sep 30, 2022 | 81.99 Mn |
| Jun 30, 2022 | 81.99 Mn |
| Mar 31, 2022 | 81.99 Mn |
| Dec 31, 2021 | 81.99 Mn |
| Sep 30, 2021 | 79.32 Mn |